CISPLATIN, EPIRUBICIN AND VP 16-213 (CEV) AS INDUCTION REGIMEN IN SMALL-CELL LUNG-CANCER (SCLC)

被引：0
|
作者：
SCAGLIOTTI, GV [1 ]
GOZZELINO, F [1 ]
DAPUZZO, C [1 ]
ALBERA, C [1 ]
BARDESSONO, F [1 ]
PESCETTI, G [1 ]
机构：
[1] UNIV TURIN,SAN LUIGI GONZAGA HOSP,DEPT PULM DIS,I-10124 TURIN,ITALY
来源：
EUROPEAN JOURNAL OF RESPIRATORY DISEASES | 1986年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A148 / A148
页数：1
相关论文
共 50 条
  • [1] CHEMOTHERAPY WITH CISPLATINUM (CDDP) AND VP-16-213 IN SMALL-CELL LUNG-CANCER (SCLC)
    IYER, PR
    MORAN, EM
    KANESHIRO, CA
    CHEN, JJ
    OTTENHEIMER, EJ
    CLINICAL RESEARCH, 1987, 35 (03): : A524 - A524
  • [2] MONO AND COMBINATION CHEMOTHERAPY WITH VP 16-213 IN SMALL CELL LUNG-CANCER (SLC)
    BRUNNER, K
    JUNGI, W
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 308 - 308
  • [3] CARBOPLATIN AND VP16-213 WITH RADIOTHERAPY (RT) AS INITIAL TREATMENT FOR PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)
    OLVER, IN
    RAGHAVAN, D
    BISHOP, JF
    MORSTYN, G
    KEFFORD, R
    STUARTHARRIS, R
    ARONEY, R
    BALL, D
    FOX, R
    HILLCOAT, B
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 62 - 62
  • [4] HIGH-DOSE VP-16-213 WITH VINCRISTINE AND ADRIAMYCIN IN THE TREATMENT OF SMALL-CELL LUNG-CANCER (SCLC)
    CALMAN, F
    BELLAMY, D
    FAREBROTHER, M
    TIMOTHY, A
    BATEMAN, N
    RUBENS, R
    COSTELLO, J
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 46 - 46
  • [5] IFOSFAMIDE, EPIRUBICIN AND CISPLATIN (IEP) - ANOTHER ACTIVE COMBINATION FOR SMALL-CELL LUNG-CANCER (SCLC)
    THONGPRASERT, S
    JIAMSRIPONGES, K
    LUNG CANCER, 1993, 10 (1-2) : 91 - 94
  • [6] CARBOPLATIN, EPIRUBICIN, AND VP-16 CHEMOTHERAPY IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
    GRIDELLI, C
    IANNIELLO, GP
    MAIORINO, A
    CURCIO, C
    DAPRILE, M
    BRANCACCIO, L
    PALMERI, S
    GENTILE, M
    COMELLA, G
    PEDICINI, T
    AIROMA, G
    VELTRI, E
    GEBBIA, V
    RUSSO, A
    CASARETTI, R
    GIAMPAGLIA, F
    FERRANTE, G
    RAUSA, L
    IACOBELLI, S
    ARCANGELI, G
    DEPLACIDO, S
    BIANCO, AR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (02): : 160 - 167
  • [7] CISPLATIN-VP16 ALTERNATING WITH CYCLOPHOSPHAMIDE-EPIRUBICIN VERSUS CYCLOPHOSPHAMIDE-EPIRUBICIN-VINCRISTINE IN SMALL-CELL LUNG-CANCER
    FARRIS, A
    BISAIL, M
    SAROBBA, MG
    SANNA, G
    SCOTTO, T
    VALZELLI, S
    INTINI, C
    JOURNAL OF CHEMOTHERAPY, 1993, 5 (05) : 344 - 347
  • [8] THE USE OF VP-16 PLUS CISPLATIN DURING INDUCTION CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER
    EVANS, WK
    FELD, R
    MURRAY, N
    PATER, J
    SHELLEY, W
    WILLAN, A
    OSOBA, D
    LEVITT, M
    COY, P
    HODSON, I
    PAYNE, DG
    MACDONALD, AS
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 10 - 16
  • [9] VP-16, IFOSFAMIDE AND CISPLATIN (VIP) FOR EXTENSIVE SMALL-CELL LUNG-CANCER
    EVANS, WK
    STEWART, DJ
    SHEPHERD, FA
    LOGAN, D
    GOSS, G
    MAROUN, JA
    WIERZBICKI, R
    WARNER, E
    LATREILLE, J
    DAHROUGE, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (03) : 299 - 303
  • [10] INITIAL THERAPY WITH CISPLATIN PLUS VP-16 IN SMALL-CELL LUNG-CANCER
    EINHORN, LH
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 5 - 9
12345